Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Return on Equity (2021 - 2025)

RxSight's Return on Equity history spans 5 years, with the latest figure at 0.14% for Q4 2025.

  • For Q4 2025, Return on Equity fell 14.0% year-over-year to 0.14%; the TTM value through Dec 2025 reached 0.14%, down 14.0%, while the annual FY2025 figure was 0.14%, 14.0% down from the prior year.
  • Return on Equity reached 0.14% in Q4 2025 per RXST's latest filing, down from 0.03% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.08% in Q3 2021 to a low of 0.72% in Q4 2022.
  • Average Return on Equity over 5 years is 0.18%, with a median of 0.12% recorded in 2021.
  • Peak YoY movement for Return on Equity: tumbled -72bps in 2022, then soared 42bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.0% in 2021, then tumbled by -2077067bps to 0.72% in 2022, then skyrocketed by 58bps to 0.3% in 2023, then surged by 100bps to 0.0% in 2024, then crashed by -80364bps to 0.14% in 2025.
  • Per Business Quant, the three most recent readings for RXST's Return on Equity are 0.14% (Q4 2025), 0.03% (Q3 2025), and 0.02% (Q2 2025).